Metastatic tumor cells of distinct developmental tumor stages exhibited differential sensitivities to NK cell surveillance in patient and mouse models in a SOX9-dependent resistance mechanism-dependent manner and displayed context-dependent adaptation and immune evasion as demonstrated by scRNA-seq [92]. The gene discussed is SOX9; the disease is neoplasm.